Magnum Pharmatech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 31-07-2024
- Paid Up Capital ₹ 0.43 M
as on 31-07-2024
- Company Age 36 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.05 Cr
as on 31-07-2024
- Revenue %
(FY 2023)
- Profit -60.00%
(FY 2023)
- Ebitda -60.00%
(FY 2023)
- Net Worth -0.25%
(FY 2023)
- Total Assets -0.13%
(FY 2023)
About Magnum Pharmatech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.43 M.
The company currently has active open charges totaling ₹4.05 Cr.
Ramesh Mahapatra and Geetarani Padhi serve as directors at the Company.
- CIN/LLPIN
U24246OR1987PTC001960
- Company No.
001960
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 1987
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Bhubaneswar, Orissa, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Magnum Pharmatech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Mahapatra  | Director | 23-Jun-1989 | Current |
| Geetarani Padhi | Director | 30-Dec-1987 | Current |
Financial Performance of Magnum Pharmatech.
Magnum Pharmatech Pvt Ltd, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 60% decrease in profit. The company's net worth dipped by a decrease of 0.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Magnum Pharmatech?
In 2023, Magnum Pharmatech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Magnum Sizzles Private LimitedActive 13 years 8 monthsRamesh Mahapatra and Geetarani Padhi are mutual person
- Magnum Sea Foods LimitedActive 37 years 1 month
Ramesh Mahapatra and Geetarani Padhi are mutual person
- Magnum Polymers Private LimitedActive 45 years 11 months
Ramesh Mahapatra and Geetarani Padhi are mutual person
- Magnum Fibres Private LimitedActive 34 years 4 months
Ramesh Mahapatra and Geetarani Padhi are mutual person
- Magnum Telesoft Private LimitedActive 27 years 7 months
Ramesh Mahapatra and Geetarani Padhi are mutual person
- Magnum Estates LimitedActive 31 years 6 months
Ramesh Mahapatra and Geetarani Padhi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 21 Dec 2023 | ₹4.00 Cr | Open |
State Bank Of India Creation Date: 26 Feb 1997 | ₹0.08 M | Open |
Andhra Bank Creation Date: 30 May 1989 | ₹0.20 M | Open |
How Many Employees Work at Magnum Pharmatech?
Unlock and access historical data on people associated with Magnum Pharmatech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Magnum Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magnum Pharmatech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
